These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16102469

  • 1. Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation.
    Apostolopoulou SC, Papagiannis J, Rammos S.
    J Heart Lung Transplant; 2005 Aug; 24(8):1174-6. PubMed ID: 16102469
    [Abstract] [Full Text] [Related]

  • 2. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.
    Hebert A, Mikkelsen UR, Thilen U, Idorn L, Jensen AS, Nagy E, Hanseus K, Sørensen KE, Søndergaard L.
    Circulation; 2014 Dec 02; 130(23):2021-30. PubMed ID: 25446057
    [Abstract] [Full Text] [Related]

  • 3. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.
    Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S.
    Heart; 2005 Nov 02; 91(11):1447-52. PubMed ID: 15761050
    [Abstract] [Full Text] [Related]

  • 4. Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study.
    Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S.
    Heart; 2007 Mar 02; 93(3):350-4. PubMed ID: 16980516
    [Abstract] [Full Text] [Related]

  • 5. Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?
    Schuuring MJ, Vis JC, Bouma BJ, van Dijk AP, van Melle JP, Pieper PG, Vliegen HW, Sieswerda GT, Mulder BJ.
    Contemp Clin Trials; 2011 Jul 02; 32(4):586-91. PubMed ID: 21527360
    [Abstract] [Full Text] [Related]

  • 6. Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery.
    Hirono K, Yoshimura N, Taguchi M, Watanabe K, Nakamura T, Ichida F, Miyawaki T.
    J Thorac Cardiovasc Surg; 2010 Aug 02; 140(2):346-51. PubMed ID: 20434177
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hemodynamic evaluation for closing interatrial communication after fenestrated Fontan operation.
    Senzaki H, Naito C, Masutani S, Nogaki M, Ohono A, Kobayashi J, Sasaki N, Asano H, Shunei K, Yokote Y, Kobayashi T.
    J Thorac Cardiovasc Surg; 2001 Jun 02; 121(6):1200-2. PubMed ID: 11385391
    [No Abstract] [Full Text] [Related]

  • 10. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.
    Schuuring MJ, Vis JC, van Dijk AP, van Melle JP, Vliegen HW, Pieper PG, Sieswerda GT, de Bruin-Bon RH, Mulder BJ, Bouma BJ.
    Eur J Heart Fail; 2013 Jun 02; 15(6):690-8. PubMed ID: 23361871
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of bosentan in patients with a failing Fontan circulation.
    Ovaert C, Thijs D, Dewolf D, Ottenkamp J, Dessy H, Moons P, Gewillig M, Mertens L.
    Cardiol Young; 2009 Aug 02; 19(4):331-9. PubMed ID: 19519964
    [Abstract] [Full Text] [Related]

  • 13. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
    van Loon RL, Hoendermis ES, Duffels MG, Vonk-Noordegraaf A, Mulder BJ, Hillege HL, Berger RM.
    Am Heart J; 2007 Oct 02; 154(4):776-82. PubMed ID: 17893008
    [Abstract] [Full Text] [Related]

  • 14. Extracardiac off-pump fontan completion for single ventricle with dextrocardia.
    Goksel OS, Gok E, Tireli E, Dayioglu E.
    Innovations (Phila); 2013 Oct 02; 8(1):73-5. PubMed ID: 23571798
    [Abstract] [Full Text] [Related]

  • 15. Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation.
    Agnoletti G, Gala S, Ferroni F, Bordese R, Appendini L, Pace Napoleone C, Bergamasco L.
    J Thorac Cardiovasc Surg; 2017 Jun 02; 153(6):1468-1475. PubMed ID: 28283234
    [Abstract] [Full Text] [Related]

  • 16. Successful management of plastic bronchitis in a child post Fontan: case report and literature review.
    Do P, Randhawa I, Chin T, Parsapour K, Nussbaum E.
    Lung; 2012 Aug 02; 190(4):463-8. PubMed ID: 22430124
    [Abstract] [Full Text] [Related]

  • 17. Long-term clinical outcome of atrial isomerism after univentricular repair.
    Hoashi T, Ichikawa H, Fukushima N, Ueno T, Kogaki S, Sawa Y.
    J Card Surg; 2009 Aug 02; 24(1):19-23. PubMed ID: 18778300
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for persistent pleural effusions after the extracardiac Fontan procedure.
    Gupta A, Daggett C, Behera S, Ferraro M, Wells W, Starnes V.
    J Thorac Cardiovasc Surg; 2004 Jun 02; 127(6):1664-9. PubMed ID: 15173721
    [Abstract] [Full Text] [Related]

  • 19. Impact of age at Fontan completion on postoperative hemodynamics and long-term aerobic exercise capacity in patients with dominant left ventricle.
    Shiraishi S, Yagihara T, Kagisaki K, Hagino I, Ohuchi H, Kobayashi J, Kitamura S.
    Ann Thorac Surg; 2009 Feb 02; 87(2):555-60; discussion 560-1. PubMed ID: 19161779
    [Abstract] [Full Text] [Related]

  • 20. Plastic bronchitis; a serious complication of the Fontan operation.
    Tzifa A, Robards M, Simpson JM.
    Int J Cardiol; 2005 Jun 08; 101(3):513-4. PubMed ID: 15907428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.